Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1012761

Functional mismatch repair and inactive p53 drive sensitization of colorectal cancer cells to irinotecan via the IAP antagonist BV6


Tomičić, Maja T.; Steigerwald, Christian; Rasenberger, Birgit; Brozović, Anamaria; Christmann, Markus
Functional mismatch repair and inactive p53 drive sensitization of colorectal cancer cells to irinotecan via the IAP antagonist BV6 // Archives of toxicology, 93 (2019), 8; 2265-2277 doi:10.1007/s00204-019-02513-7 (međunarodna recenzija, članak, znanstveni)


CROSBI ID: 1012761 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Functional mismatch repair and inactive p53 drive sensitization of colorectal cancer cells to irinotecan via the IAP antagonist BV6

Autori
Tomičić, Maja T. ; Steigerwald, Christian ; Rasenberger, Birgit ; Brozović, Anamaria ; Christmann, Markus

Izvornik
Archives of toxicology (0340-5761) 93 (2019), 8; 2265-2277

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
IAP antagonist ; Irinotecan ; Colorectal cancer ; Mismatch repair ; p53 ; NF-κB

Sažetak
A common strategy to overcome acquired chemotherapy resistance is the combination of a specific anticancer drug (e.g., topoisomerase I inhibitor irinotecan) together with a putative sensitizer. The purpose of this study was to analyze the cytostatic/cytotoxic response of colorectal carcinoma (CRC) cells to irinotecan, depending on the mismatch repair (MMR) and p53 status and to examine the impact of BV6, a bivalent antagonist of inhibitors of apoptosis c-IAP1/c-IAP2, alone or combined with irinotecan. Therefore, several MSH2- or MSH6-deficient cell lines were complemented for MMR deficiency, or MSH6 was knocked out/down in MMR-proficient cells. Upon irinotecan, MMR-deficient/p53-mutated lines repaired DNA double- strand breaks by homologous recombination less efficiently than MMR-proficient/p53-mutated lines and underwent elevated caspase- 9-dependent apoptosis. Opposite, BV6-mediated sensitization was achieved only in MMR-proficient/p53-mutated cells. In those cells, c- IAP1 and c-IAP2 were effectively degraded by BV6, caspase-8 was fully activated, and both canonical and non-canonical NF-κB signaling were triggered. The results were confirmed ex vivo in tumor organoids from CRC patients. Therefore, the particular MMR+/p53mt signature, often found in non-metastasizing (stage II) CRC might be used as a prognostic factor for an adjuvant therapy using low-dose irinotecan combined with a bivalent IAP antagonist.

Izvorni jezik
Engleski

Znanstvena područja
Biologija, Temeljne medicinske znanosti



POVEZANOST RADA


Ustanove
Institut "Ruđer Bošković", Zagreb

Profili:

Avatar Url Anamaria Brozović (autor)

Avatar Url Maja Tomičić (autor)

Citiraj ovu publikaciju

Tomičić, Maja T.; Steigerwald, Christian; Rasenberger, Birgit; Brozović, Anamaria; Christmann, Markus
Functional mismatch repair and inactive p53 drive sensitization of colorectal cancer cells to irinotecan via the IAP antagonist BV6 // Archives of toxicology, 93 (2019), 8; 2265-2277 doi:10.1007/s00204-019-02513-7 (međunarodna recenzija, članak, znanstveni)
Tomičić, M., Steigerwald, C., Rasenberger, B., Brozović, A. & Christmann, M. (2019) Functional mismatch repair and inactive p53 drive sensitization of colorectal cancer cells to irinotecan via the IAP antagonist BV6. Archives of toxicology, 93 (8), 2265-2277 doi:10.1007/s00204-019-02513-7.
@article{article, year = {2019}, pages = {2265-2277}, DOI = {10.1007/s00204-019-02513-7}, keywords = {IAP antagonist, Irinotecan, Colorectal cancer, Mismatch repair, p53, NF-κB}, journal = {Archives of toxicology}, doi = {10.1007/s00204-019-02513-7}, volume = {93}, number = {8}, issn = {0340-5761}, title = {Functional mismatch repair and inactive p53 drive sensitization of colorectal cancer cells to irinotecan via the IAP antagonist BV6}, keyword = {IAP antagonist, Irinotecan, Colorectal cancer, Mismatch repair, p53, NF-κB} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati